Helix Acquisition Corp II
HLXB9.900USD
0.000
Market hours （ET）Quotes delayed by 15 min
232.74MMarket Cap
48.70P/E TTM
More Details of Helix Acquisition Corp II Company
Helix Acquisition Corp. II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which it refers to as its initial business combination. The Company has not selected any specific business combination target and it has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any business combination. While it may pursue a business combination target in any business or industry, it intends to focus on healthcare or healthcare related industries. The Company has not generated any revenue.
Helix Acquisition Corp II Info
Ticker SymbolHLXB
Company nameHelix Acquisition Corp II
IPO dateFeb 09, 2024
CEOMs. Bihua Chen
Number of employees- -
Security typeOrdinary Share
Fiscal year-endFeb 09
AddressC/O Cormorant Asset Management, Lp
CityBOSTON
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code02116
Phone18577020377
Website
Ticker SymbolHLXB
IPO dateFeb 09, 2024
CEOMs. Bihua Chen
Company Executives of Helix Acquisition Corp II
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Oct 28
Updated: Tue, Oct 28
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Cormorant Asset Management, LP
22.57%
BridgeBio Pharma, Inc.
18.42%
Deerfield Management Company, L.P.
6.17%
BC Global Opportunities IX LP
5.51%
BlackRock Financial Management, Inc.
1.84%
Other
45.48%
Shareholders
Shareholders
Proportion
Cormorant Asset Management, LP
22.57%
BridgeBio Pharma, Inc.
18.42%
Deerfield Management Company, L.P.
6.17%
BC Global Opportunities IX LP
5.51%
BlackRock Financial Management, Inc.
1.84%
Other
45.48%
Shareholder Types
Shareholders
Proportion
Hedge Fund
39.41%
Corporation
23.93%
Investment Advisor
4.05%
Investment Advisor/Hedge Fund
2.43%
Research Firm
1.09%
Private Equity
0.50%
Individual Investor
0.11%
Other
28.47%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
53
37.60M
47.48%
+20.03M
2025Q2
45
24.80M
131.18%
+8.09M
2025Q1
44
17.89M
94.60%
+829.91K
2024Q4
41
17.82M
94.24%
+1.30M
2024Q3
37
17.47M
92.41%
+1.09M
2024Q2
35
17.48M
94.85%
+1.41M
2024Q1
33
17.17M
90.80%
+8.90M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Cormorant Asset Management, LP
17.88M
22.57%
+14.97M
+514.60%
Aug 29, 2025
BridgeBio Pharma, Inc.
13.81M
17.43%
+13.81M
--
Aug 29, 2025
Deerfield Management Company, L.P.
4.89M
6.17%
+4.89M
--
Aug 29, 2025
BC Global Opportunities IX LP
4.37M
5.51%
+3.27M
+296.89%
Sep 04, 2025
BlackRock Financial Management, Inc.
1.46M
1.84%
--
--
Jun 30, 2025
Citadel Advisors LLC
1.43M
1.8%
+15.24K
+1.08%
Jun 30, 2025
Adage Capital Management, L.P.
1.40M
1.77%
--
--
Jun 30, 2025
T. Rowe Price Associates, Inc.
1.07M
1.35%
--
--
Jun 30, 2025
Sculptor Capital Management, Inc
967.46K
1.22%
+167.46K
+20.93%
Jul 17, 2025
Millennium Management LLC
897.25K
1.13%
-199.13K
-18.16%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
Schwab U.S. Small-Cap ETF
0.01%
iShares Health Innovation Active ETF
0%
Schwab U.S. Broad Market ETF
0%
Schwab U.S. Small-Cap ETF
Proportion0.01%
iShares Health Innovation Active ETF
Proportion0%
Schwab U.S. Broad Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
